On the Determinants of Discount Rates in Discounted Cash Flow Valuations: A Counterfactual Analysis
Real Estate · 2024
DOI: 10.3390/realestate1020009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Real Estate, 2024. Verfasst von Joël Vonlanthen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This study addresses the scarcity of empirical findings on the determinants of discount rates in the Discounted Cash Flow (DCF) method, filling a crucial gap in the existing literature and enhancing the understanding of the valuation process from the perspectives of key stakeholders. Leveraging a unique dataset comprising market transactions enriched with expert-based valuation information, the study conducts a comprehensive counterfactual analysis of the fundamental determinants influencing both appraisal-based and transaction-based discount rates. The results reveal that appraisers and investors attribute different levels of importance to object-specific, locational, and macroeconomic variables. A type-specific analysis further reveals that locational and macroeconomic variables exert a greater influence on discount rates in the residential real estate segment. In contrast, object-specific characteristics hold significantly higher importance in explaining discount rates in the commercial real estate segment.
Zitieren
APA
Vonlanthen, J. (2024). On the Determinants of Discount Rates in Discounted Cash Flow Valuations: A Counterfactual Analysis. Real Estate. https://doi.org/10.3390/realestate1020009
Vancouver
Vonlanthen J. On the Determinants of Discount Rates in Discounted Cash Flow Valuations: A Counterfactual Analysis. Real Estate. 2024. doi:10.3390/realestate1020009
BibTeX
@article{Vonlanthen2024,
author = {Vonlanthen, Joël},
title = {On the Determinants of Discount Rates in Discounted Cash Flow Valuations: A Counterfactual Analysis},
journal = {Real Estate},
year = {2024},
doi = {10.3390/realestate1020009}
}
EUVIMED